Ill Effects Of Marketing Free Drugs

Working in health care handling prescription drugs is something that most nurses probably do not think twice about. That is until you are asked to decrease the frequency in which you are giving a medication. Though the prescription drug shortage is not something we may necessarily think about on a day to day basis, it is something that affects everyone in healthcare. The shortages affect what treatment options a patient may have or determining if there are other medications for substitution in the event the production of a drug is halted. Though we think

When making the decision to prescribe there are a number of influence you have to consider. It is important to have an awareness of these influences and take them into consideration when issuing a prescription. It is importance to have knowledge of the DOH (2006) Medicines Matters this give guidance on the mechanisms available for prescribing and administration and supply of products. Team trends and external company’s and there representatives promoting their products have a big influence on your prescribing practice Bradley (2006) found that these influences were of concern to some nurses feeling that their colleague may ask them to prescribe for patients they haven’t seen. Thomas (2008)

Ads for pharmaceutical drugs are everywhere. They are in magazines, on television and radio, on billboards, and on the little bags that you get from the pharmacist. These days it is difficult to get away from all the drug advertising. All these ads are for products that require a doctor's prescription. The goal of advertising is to increase profits. By advertising so heavily for drugs that the majority of the population does not need, pharmaceutical companies attempt to create as large a consumer base as they can. In advertising directly to the consumer, the drug companies accomplish two objectives. First, they get information directly to the consumer. Second, they promote the product and

"In the past two decades or so, health care has been commercialized as never before, and professionalism in medicine seems to be giving way to entrepreneurialism," commented Arnold S. Relman, professor of medicine and social medicine at Harvard Medical School (Wekesser 66). This statement may have a great deal of bearing on reality. The tangled knot of insurers, physicians, drug companies, and hospitals that we call our health system are not as unselfish and focused on the patients' needs as people would like to think. Pharmaceutical companies are particularly ruthless, many of them spending millions of dollars per year to convince doctors to prescribe their drugs and to convince consumers that their specific brand of drug is needed in

If you have ever watched TV in America you are aware of “direct-to consumer" (DTC) advertising for prescription drugs. These are ads provided by drug companies in the intent to educate the general public on the benefits of their product. They often feature celebrities or catchy cartoons with very healthy satisfied patients. This type of advertising of prescription drugs is unique to the United States. It was one of only two countries that allows DTC advertising. New Zealand is the only other developed nation that does. If the intent is to educate the prospective consumers about their product then why do only two countries utilize the technique (“For Consumers”)?

In 2015, the pharmaceutical industry spent over 27 billion dollars on advertising. The two greatest components of this effort were promotional advertising and free medication sampling, which the pharmaceuticals invested 15.5 and 5.7 billion dollars respectively (“Persuading the Prescribers”). Promotional advertising involves direct contact with health professionals, the most common being extravagant lunch conferences held for physicians and their staff. On the other hand, sampling involves distributing free sample of medications to physicians, who then have a choice of providing these samples to patients. As a result of these methods, the industry has seen revenue around $400 billion with 90% of physicians having a relationship with a drug company (Campbell 2007). Moreover, the prices of prescriptions continue to rise; a copay of a generic drug is $11.72, preferred brand drug is $36.37 and a specialty drug is $58.37 (Coleman and Geneson 2014). Although the profits are immense in the numbers demonstrated above, it is no surprise when pharmaceutical drug companies elevate their prices even more. For instance, recently Turing Pharmaceuticals raised the price of their medication Daraprim from $13.50 to $750. Keep in mind, this medication is used for threatening parasitic infections, aids, and cancer with alternative options currently found to be inefficient (Pollack 2015). Another example of this practice involves cycloserine, a drug used to

Shortages of prescription drugs in the United States are a serious threat to our nation’s health and safety. At first blush, this problem appears fairly simple and straight forward to solve. In reality, there is a complex web of causation with a number of root causes contributing to drug shortages. The aim of this paper is to answer the question: How do we mitigate prescription drug shortages? This discussion is written from the standpoint of advising the current presidential administration how to address this crisis. This essay begins with a discussion regarding the background of the issue. Next, the landscape, including stakeholders in this matter is identified. Following, political, social, economic, and practical factors surrounding

New Zealand is the only other developed nation in the world where prescription drugs are advertised directly to consumers. The American pharmaceutical industry used to abide by a term “ethical marketing,” meaning that drug companies could only market to physicians. On the other hand, there is a valid argument for allowing direct-to-consumer drug advertisements as the flow of information and transparency are beneficial. However, there obviously needs to be some checks and balances. This experiment began with a print advertisement in 1981 in Reader’s Digest and the first TV ad took place in 1983. At that time, the FDA had several rules in place requiring companies to offer a fair and balanced presentation. In sum, this was a responsible era of advertising.

Prescription drug abuse, now known as the “silent epidemic,” is spreading rapidly in the United States, so who’s to blame? This essay will argue that oftentimes, pharmaceutical companies are responsible for luring the opioid dependent population, and more often than not, causing their deaths. It is their greed that over powers the true meaning of medicine. One would think that millions of dollars in profits would be enough. However, considering it is a multibillion dollar industry, apparently not. Selfishness shown by bribery, false advertisements and “the Domino Effect,” will reveal that they are truly guilty.

People all over the world, continue to be tendered prescription medication, which in many cases further complicate health issues with its myriad of side effects. In fact, statistics have shown that approximately 100,000 people around the world die as a result of prescription drugs annually (Smith, 2012). On the contrary, according

The rise in costs of prescription medicines affects all sectors of the health care industry, including private insurers, public programs, and patients. Spending on prescription drugs continues to be an important health care concern, particularly in light of rising pharmaceutical costs, the aging population, and increased use of costly specialty drugs. In recent history, increases in prescription drug costs have outpaced other categories of health care spending, rising rapidly throughout the latter half of the 1990s and early 2000s. (Kaiseredu.org, 2012).

In the United States of America, there is prescription drug abuse epidemic that continues to be a growing concern. Prescription drugs cause a large amount of overdoses and result in an abundant amount of deaths each year. A government study conducted shows this epidemic is scarily on the rise, “A recent government study found a 400% increase in prescription drug abuse between 1998 and 2008” (Schreiner 531). The excessive use of prescription drug abuse is leading to nonmedical use of the drugs, and creating addiction. Furthermore society is paying an extreme amount of money in this battle. With this drug abuse on the rise, legislators must create a law preventing doctors and pharmacists from over prescribing prescription medications as well a law to require they both participate in drug monitoring programs to prevent drug abuse. Now is the time that doctors and the pharmaceutical industry must be held accountable for their role in causing one of America’s worst addictions. The over medication of prescription drugs in the United States must be brought to an end by legislators creating laws to stop

There are many direct to consumer advertising for prescription drugs. On television, magazines, radio etc, you see the most recent advertisements for prescription drugs. After some people see the advertisements they soon rush over to their doctor and their illness and life would be perfectly pain and stress free. Making the public conscious of options for treatment is not a bad thing. But these false advertisements are misleading consumers onto unnecessary treatment.

In the articles “Prescription Drug Ads Should Be Better Regulated” and “Prescription Drug Advertising Empowers Patients”, the authors discuss the impact of prescription drug advertising on drug costs, consumer behaviors and consumers and Doctors’ relationship. While pharmaceutical companies support prescription drug advertising because they think that its effects are positive, Naomi Freundlich claims that prescription drug advertise should be more controlled. Because “Administration is underfunded and lacks the resources to enforce many of the regulations that are already in place” “big pharmaceutical companies must do a better job with self-regulation” (Naomi) in order to reduce the negative consequences of prescription drugs ads.

According to Article 182.6 of the Healthcare Code medical employees and pharmacists is obliged to meet with its professional obligations, validly and humanely to treat patients, to be guided by the principles of medical ethics. In its turn, according to Article 184 of the Health Code medical employees and pharmacists shall prevent promotion and use of methods and means of prevention and treatment for their personal profit. The activity mentioned in Question 6 may entail promotion of Company’s product by pharmacist for purposes of obtaining of personal profit. In respect of this, we are of the view, that this type of stimulation of pharmacist will be not in line with Code of Honor of medical employees and may not be